Stocks · News reference
Renewed certification maintains Kincardine’s role in Canopy Growth’s EU GMP flower supply chainCanopy Growth Corporation ("Canopy Growth", "our", "we" or the "Company") (TSX:WEED)
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
https://x.com/DougKass/status/2093394146182480247
The cannabis sector is undergoing consolidation as weaker players exit and stronger companies acquire competitors. Curaleaf has made an unsolicited $4 per share bid for Aurora Cannabis. The article identifies Canopy Growth and Tilray Brands as the biggest potential winners in this consolidation trend, with Canopy benefiting from its balance sheet reset and Tilray diversifying beyond marijuana into alcohol and consumer brands.
Curaleaf launched an unsolicited $272 million bid to acquire Aurora Cannabis at $4 per share, signaling renewed consolidation in the cannabis industry. The move raises questions about whether Canopy Growth could become the next acquisition target. While Canopy has valuable global medical cannabis assets and established brands, its complex corporate structure and ongoing turnaround make it a less obvious fit for potential acquirers.
Canopy Gwth (TSX:WEED) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.10) by 66.67 percent. This is a 86.36 percent increase over losses of $(0.22) per share from the
Canopy Gwth (TSX:WEED) released fourth-quarter financial results and hosted an earnings call on Monday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and